General MedicationsINTRAMUSCULARGeneric

MORPHINE SULFATE (AUTOINJECTOR)

MORPHINE SULFATE

Standard Dose

10MG/0.7ML (10MG/0.7ML)

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview MORPHINE SULFATE (AUTOINJECTOR) is listed in Drugs@FDA under application 019999 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient MORPHINE SULFATE Form and strength SOLUTION;INTRAMUSCULAR - 10MG/0.7ML (10MG/0.7ML) Sponsor MERIDIAN MEDCL TECHN Submission history Latest submission status date: 2019-10-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview MORPHINE SULFATE (AUTOINJECTOR) is listed in Drugs@FDA under application 019999 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MORPHINE SULFATE Form and strength SOLUTION;INTRAMUSCULAR - 10MG/0.7ML (10MG/0.7ML) Sponsor MERIDIAN MEDCL TECHN Submission history Latest submission status date: 2019-10-07 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.